© Copyright 2013
View Larger Map
Allon Therapeutics Inc.1168 Hamilton Street, Suite 506Vancouver, BC V6B 2S2
Copyright 2013 Allon Therapeutics Inc. See legal terms for use of this site
Allon Therapeutics Inc. is a clinical stage biotechnology company focused on commercializing high potential central nervous system drugs.
Allon’s focus is developing central nervous system therapies. Allon’s drug candidates have been shown to work at the cellular level to protect or shield neurons from injury.
Allon’s human clinical trials and animal studies show that davunetide reduces the neurodegenerative “tangles” pathology and also increases memory function.
Allon’s lead drug davunetide, is proceeding in a fully enrolled pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under an SPA with the FDA.